Some extended-release formulations of the diabetes drug metformin contained levels of a nitrosamine impurity falling above the US Food and Drug Administration’s (FDA’s) acceptable intake limit, ...

Some laboratories voluntarily recalled certain lots of the prescription drug Metformin Extended Release (ER) because it may contain N-nitrosodimethylamine (NDMA) above an acceptable intake limit.

Once cleared by the FDA of a probable carcinogen, generic diabetes med metformin has now been the target of a growing number of recalls. This week, a seventh drugmaker has joined the metformin recall ...

After the FDA identified a likely carcinogen in samples of the broadly used diabetes med metformin, recalls appeared likely. Now it's official. The FDA said Thursday it had asked five metformin ...

Apotex has recalled all its Metformin Hydrochloride Extended-Release Tablets 500 mg in the United States for too much of carcinogen NDMA, the same “impurity” that got all the Zantac yanked earlier ...

Adding metformin to letrozole and abemaciclib (Verzenio) was tied to deep responses and prolonged progression-free survival (PFS) in some patients with recurrent estrogen receptor (ER)-positive ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Whenever you start taking a new medication to treat a certain symptom or condition, it’s natural to ...